Yamamoto, Yuji
Mukai, Atsushi
Ikushima, Toru
Urata, Yasuo
Kinoshita, Shigeru
Hamuro, Junji
Ueno, Morio
Sotozono, Chie
Funding for this research was provided by:
Oncolys BioPharma, Inc., Japan
Japan Society for the Promotion of Science (JP18K09455)
Article History
Received: 14 July 2020
Accepted: 18 November 2020
First Online: 1 December 2020
Competing interests
: Y.U. is the president and CEO of Oncolys BioPharma, Inc., the manufacturer of OBP. S.K. received research support from Oncolys BioPharma, Inc. The other authors have no real or potential conflicts of interest to declare.